Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NUVB Nuvation Bio, Inc.

Post-Mkt 06-05 19:27:07 EDT

4.82

-0.35

-6.77%

盘后4.72

-0.10-2.05%

18:47 EDT

High5.14	Low4.72	Vol3.48M
Open5.10	D1 Closing5.17	Amplitude8.12%
Mkt Cap1.68B	Tradable Cap1.11B	Total Shares347.60M
T/O16.82M	T/O Rate1.50%	Tradable Shares231.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NUVB","market":"US","secType":"STK","nameCN":"Nuvation Bio, Inc.","latestPrice":4.82,"timestamp":1780689600000,"preClose":5.17,"halted":0,"volume":3475999,"hourTrading":{"tag":"盘后","latestPrice":4.7211,"preClose":4.82,"latestTime":"18:47 EDT","volume":37962,"amount":181943.1499248,"timestamp":1780699649614,"change":-0.0989,"changeRate":-0.020519,"amplitude":0.020747},"delay":0,"changeRate":-0.06769825918762082,"floatShares":231046340,"shares":347597289,"eps":-0.424745,"marketStatus":"Post-Mkt","change":-0.35,"latestTime":"06-05 19:27:07 EDT","open":5.1,"high":5.14,"low":4.72,"amount":16816386.789342802,"amplitude":0.081238,"askPrice":4.88,"askSize":500,"bidPrice":4.72,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-0.424745,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1780704000000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":5.17,"preHourTrading":{"tag":"盘前","latestPrice":5.1073,"preClose":5.17,"latestTime":"09:29 EDT","volume":20680,"amount":107469.257368,"timestamp":1780666192827,"change":-0.0627,"changeRate":-0.012128,"amplitude":0.025145},"postHourTrading":{"tag":"盘后","latestPrice":4.7211,"preClose":4.82,"latestTime":"18:47 EDT","volume":37962,"amount":181943.1499248,"timestamp":1780699649614,"change":-0.0989,"changeRate":-0.020519,"amplitude":0.020747},"volumeRatio":0.711839,"impliedVol":2.7873,"impliedVolPercentile":0.9801},"requestUrl":"/m/hq/s/NUVB/tweets","defaultTab":"tweets","newsList":[{"id":"2639764993","title":"Did New IBTROZI Quality‑of‑Life Data Just Shift Nuvation Bio’s (NUVB) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2639764993","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639764993?lang=en_us&edition=fundamental","pubTime":"2026-05-29 12:30","pubTimestamp":1780029048,"startTime":"0","endTime":"0","summary":"Nuvation Bio recently reported new patient-reported outcomes from the pivotal TRUST-II study of IBTROZI (taletrectinib) in advanced ROS1-positive non-small cell lung cancer, showing that quality-of-life and symptom burden generally improved or remained stable over time across both TKI-naïve and TKI-pretreated patients.\nThe finding that up to 96% of patients reported improved or stable coughing and shortness of breath as early as the first follow-up highlights IBTROZI’s potential to rapidly...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/did-new-ibtrozi-qualityoflife-data-just-shift-nuvation-bios","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/did-new-ibtrozi-qualityoflife-data-just-shift-nuvation-bios","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638636846","title":"Nuvation Bio held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638636846","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638636846?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:22","pubTimestamp":1779913323,"startTime":"0","endTime":"0","summary":"Nuvation Bio held its annual shareholder meeting on May 21, 2026.Shareholders selected Robert B. Bazemore, Jr., Robert Mashal, M.D., and Kim Blickenstaff as directors to serve until the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvation Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL8YDkbL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638635497","title":"Nuvation Bio to present at Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2638635497","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638635497?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:09","pubTimestamp":1779912559,"startTime":"0","endTime":"0","summary":"Nuvation Bio will join the Jefferies Global Healthcare Conference on June 3, 2026.Founder, President, CEO David Hung and CFO Philippe Sauvage are scheduled for a fireside chat at 9:55 a.m. ET in New York.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL17Sy0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638190689","title":"Nuvation Bio’s Ibtrozi shows improved quality of life in NSCLC trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2638190689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638190689?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:37","pubTimestamp":1779892652,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced new patient-reported outcomes data from the pivotal TRUST-II study of Ibtrozi – taletrectinib – in patients with adva...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bios-ibtrozi-shows-improved-quality-of-life-in-nsclc-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bios-ibtrozi-shows-improved-quality-of-life-in-nsclc-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507429","title":"Nuvation Bio to present TRUST-II quality-of-life data for IBTROZI in ROS1+ lung cancer at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507429?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:02","pubTimestamp":1779883347,"startTime":"0","endTime":"0","summary":"Nuvation Bio flagged new quality-of-life findings from the Phase 2 TRUST-II study of IBTROZI in advanced ROS1-positive NSCLC.Results will be presented May 31 at the 2026 ASCO annual meeting.Patients generally reported quality of life stayed stable or improved early in treatment, with benefits largely maintained over time.Reported cognitive function was preserved during therapy, easing concerns about neurologic side effects that can limit use of competing options.The update supports IBTROZI’s positioning in ROS1-positive lung cancer as the company pursues broader regulatory expansion, including a U.S. sNDA decision due Jan. 4, 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL8Dsgwf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638554455","title":"H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638554455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638554455?lang=en_us&edition=fundamental","pubTime":"2026-05-27 01:46","pubTimestamp":1779817573,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Nuvation Bio today and set a price target of $17.00. Burns covers the Healthcare se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638597995","title":"Analysts Are Bullish on Top Healthcare Stocks: Nuvation Bio (NUVB), Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638597995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638597995?lang=en_us&edition=fundamental","pubTime":"2026-05-26 17:01","pubTimestamp":1779786077,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nuvation Bio (NUVB), Universal Health (UHS) and Eli ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-nuvation-bio-nuvb-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-nuvation-bio-nuvb-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4185","NUVB","UHS","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637829023","title":"How Does Nuvation Bio’s (NUVB) IBTROZI Update Reframe Its Long-Term Oncology Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637829023","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637829023?lang=en_us&edition=fundamental","pubTime":"2026-05-20 23:40","pubTimestamp":1779291643,"startTime":"0","endTime":"0","summary":"Earlier this month, Nuvation Bio announced that the FDA accepted a supplemental New Drug Application for IBTROZI with additional long-term efficacy and safety data in advanced ROS1-positive non-small cell lung cancer, while also completing a U.S. manufacturing technology transfer to Thermo Fisher Scientific.\nTogether, the strengthened clinical dataset and secured domestic supply chain deepen IBTROZI’s profile as a CNS-active ROS1 therapy with growing global reach and operational...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/how-does-nuvation-bios-nuvb-ibtrozi-update-reframe-its-long","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/how-does-nuvation-bios-nuvb-ibtrozi-update-reframe-its-long","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635756493","title":"Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2635756493","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635756493?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:41","pubTimestamp":1778704895,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced the completion of process tech transfer and product introduction to Thermo Fisher (TMO) for Ibtrozi – taletrectinib –...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-collaborating-with-thermo-fisher-to-manufacture-ibtrozi-in-nsclc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-collaborating-with-thermo-fisher-to-manufacture-ibtrozi-in-nsclc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0957791311.USD","LU2089984988.USD","LU0345770308.USD","LU1791710400.SGD","LU1720051108.HKD","LU0061474960.USD","LU1548497426.USD","LU1803068623.USD","LU2041044095.USD","LU2211814178.USD","LU0342679015.USD","LU2764262908.HKD","LU0114720955.EUR","BK4535","LU1670627923.USD","BK4533","LU2764263203.CNY","IE00B4R5TH58.HKD","LU1791710582.SGD","LU2468319806.SGD","LU2125910336.SGD","BK4581","LU0557290698.USD","LU0640476718.USD","LU2298321311.HKD","LU2264538146.SGD","LU1854104046.USD","LU1815333072.USD","LU0011850046.USD","LU2125909247.SGD","BK4534","GB00BDT5M118.USD","TMO","BK4548","LU1280957306.USD","LU1923621640.USD","LU1670628061.USD","IE00B19Z8W00.USD","LU1061106388.HKD","LU2357305700.SGD","IE0002141913.USD","BK4566","LU0528227936.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","NUVB","LU1057294990.SGD","LU2092937221.SGD","LU0345770993.USD","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635753828","title":"Nuvation Bio partners with Thermo Fisher for US manufacturing of IBTROZI","url":"https://stock-news.laohu8.com/highlight/detail?id=2635753828","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635753828?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:10","pubTimestamp":1778703041,"startTime":"0","endTime":"0","summary":"Nuvation Bio completed a process tech transfer to Thermo Fisher Scientific for U.S.-based final drug product manufacturing of IBTROZI , its ROS1-positive non-small cell lung cancer therapy.Transition was submitted as a supplement to IBTROZI New Drug Application held by Nuvation Bio, with work now complete.Shift moves commercial supply closer to US patients, targeting supply continuity for an FDA-approved oncology product.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL5GQ8yj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096362180.USD","NUVB","LU2211814178.USD","LU0882574055.USD","LU2764262908.HKD","LU1712237335.SGD","LU0528227936.USD","LU2543165471.USD","BK4534","IE00BQXX3C00.GBP","LU1854103824.USD","LU1923622614.USD","LU2360108059.USD","LU2433249047.HKD","LU0122379950.USD","BK4581","LU0234572021.USD","BK4566","BK4533","IE00B2B36J28.USD","LU1803068623.USD","LU0316494557.USD","LU1623119135.USD","LU0345770308.USD","LU2468319806.SGD","LU1153585028.USD","LU1923621640.USD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU1670628061.USD","LU1023059063.AUD","LU2092937221.SGD","LU2063271972.USD","IE00B19Z8W00.USD","LU1791710582.SGD","LU0345770993.USD","LU1633808545.USD","IE0009355771.USD","LU0342679015.USD","LU1983299246.USD","LU2125910336.SGD","TMO","LU2125910179.SGD","LU1061106388.HKD","LU2125909247.SGD","LU1548497426.USD","IE00B1BXHZ80.USD","BK4535","LU0208291251.USD","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635775810","title":"Nuvation Bio to Collaborate With Thermo Fisher Scientific for U.S.-Based Manufacturing of Ibtrozi® for Ros1-Positive Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2635775810","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635775810?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:05","pubTimestamp":1778702703,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA9SZWNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633116138","title":"Nuvation Bio says FDA accepts IBTROZI label update filing for ROS1+ NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2633116138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633116138?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:07","pubTimestamp":1778069269,"startTime":"0","endTime":"0","summary":"Nuvation Bio disclosed FDA acceptance of supplemental new drug application seeking to update US label for IBTROZI  in advanced ROS1-positive non-small cell lung cancer, with agency target action date set for Jan. 4, 2027.Filing reflects longer follow-up from pivotal TRUST-I, TRUST-II studies, pointing to sustained patient benefit in both previously untreated, previously treated settings without detailing new safety concerns.Updated study results were already presented at AACR 2026.Move follows IBTROZI full US approval in June 2025, supporting longer-duration efficacy claims that could strengthen positioning across lines of therapy.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL7rVF7P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633118009","title":"Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for Ibtrozi® (Taletrectinib) With Updated Duration of Response in Advanced Ros1-Positive Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2633118009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633118009?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068817,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA745RWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633001180","title":"Nuvation Bio Inc - FDA Accepts Supplemental Nda for Ibtrozi in Advanced Ros1+ Nsclc; Target Action Date Jan 4, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2633001180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633001180?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068817,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA745RWQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633264729","title":"Nuvation Bio participates in Bank of America Securities Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2633264729","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633264729?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:09","pubTimestamp":1778011794,"startTime":"0","endTime":"0","summary":"Nuvation Bio will take part in investor conference fireside chats, starting May 13, 2026 at Bank of America Securities 2026 Healthcare Conference in Las Vegas.New York events scheduled May 19, 2026 at H.C. Wainwright BioConnect conference, May 20, 2026 at RBC Capital Markets Global Healthcare Conference.Virtual appearance set for May 26, 2026 at TD Cowen 7th Annual Oncology Innovation Summit.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL5PSYfF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119179931","title":"Stock Track | Nuvation Bio Soars 5.33% Intraday on Positive Analyst Coverage and Maintained Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=1119179931","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119179931?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:53","pubTimestamp":1777992830,"startTime":"0","endTime":"0","summary":"Shares of Nuvation Bio, Inc. (NUVB) surged 5.33% during Tuesday's intraday trading session, marking a significant upward movement for the healthcare stock.The stock's rise appears to be driven by...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149912","title":"Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149912?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:21","pubTimestamp":1777980070,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB). A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adc-therapeutics-adct-evolus-eols-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adc-therapeutics-adct-evolus-eols-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EOLS","LABU","BK4080","BK4007","BK4139","BK4137","LU0128526141.USD","LU0029874061.USD","BK4505","XLV","ADC","BK4231","BK4581","HCSG","XBI","BK4585","NUVB","ADCT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633919492","title":"Nuvation Bio Price Target Maintained With a $17.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633919492","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633919492?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:34","pubTimestamp":1777977240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 06:34 ET (10:34 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633969417","title":"Earnings Flash (NUVB) Nuvation Bio Posts Q1 EPS $0.01, vs. FactSet Est of $0.03 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2633969417","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633969417?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:51","pubTimestamp":1777927906,"startTime":"0","endTime":"0","summary":"Earnings Flash (NUVB) Nuvation Bio Posts Q1 EPS $0.01, vs. FactSet Est of $0.03 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633296999","title":"Nuvation Bio publishes corporate presentation on IBTROZI ROS1 lung cancer drug```","url":"https://stock-news.laohu8.com/highlight/detail?id=2633296999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633296999?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:43","pubTimestamp":1777927418,"startTime":"0","endTime":"0","summary":"Nuvation Bio highlighted IBTROZI  as its commercial anchor, citing FDA clearance for advanced ROS1+ NSCLC in June 2025.U.S. net product revenue reached USD 24.7 million in 2025, rising to USD 18.5 million in Q1 2026.Launch metrics showed more than 600 new patient starts as of March 31, 2026, with over 50% of Q1 starts in TKI-nave patients.Pipeline focus centered on safusidenib, a brain-penetrant IDH1 inhibitor enrolling in pivotal SIGMA study in IDH1-mutant astrocytoma with high-risk features.Pro forma cash balance was about USD 534 million as of March 31, 2026, framed as sufficient to support path to profitability without additional funding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvation Bio Inc. published the original conten","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL8dhYhf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0884},{"period":"1month","weight":0.0704},{"period":"3month","weight":0.1264},{"period":"6month","weight":-0.3953},{"period":"1year","weight":1.1102},{"period":"ytd","weight":-0.423}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":0.046},{"period":"3month","weight":0.126},{"period":"6month","weight":0.1041},{"period":"1year","weight":0.2704},{"period":"ytd","weight":0.1102}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung , M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco .","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.099824},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044723},{"month":3,"riseRate":0.5,"avgChangeRate":0.083814},{"month":4,"riseRate":0.5,"avgChangeRate":0.010626},{"month":5,"riseRate":0.666667,"avgChangeRate":0.014611},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.062165},{"month":7,"riseRate":0.6,"avgChangeRate":0.065913},{"month":8,"riseRate":0.6,"avgChangeRate":0.013694},{"month":9,"riseRate":0.5,"avgChangeRate":-0.038205},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.016548},{"month":11,"riseRate":0.5,"avgChangeRate":0.163132},{"month":12,"riseRate":0.666667,"avgChangeRate":0.061496}],"exchange":"NYSE","name":"Nuvation Bio, Inc.","nameEN":"Nuvation Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Nuvation Bio, Inc.,NUVB,Nuvation Bio, Inc.股票,Nuvation Bio, Inc.股票老虎,Nuvation Bio, Inc.股票老虎国际,Nuvation Bio, Inc.行情,Nuvation Bio, Inc.股票行情,Nuvation Bio, Inc.股价,Nuvation Bio, Inc.股市,Nuvation Bio, Inc.股票价格,Nuvation Bio, Inc.股票交易,Nuvation Bio, Inc.股票购买,Nuvation Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}